The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular analysis for therapy choice (MATCH) arm W: Phase II study of AZD4547 in patients with tumors with aberrations in the FGFR pathway.
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health
Speakers' Bureau - Genentech/Roche; Genentech/Roche; merck
Travel, Accommodations, Expenses - Hanmi
 
Christos Vaklavas
No Relationships to Disclose
 
Heather H. Cheng
Research Funding - Astellas Medivation; Inovio Pharmaceuticals; Janssen; Sanofi
 
Fangxin Hong
No Relationships to Disclose
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
James A. Zwiebel
No Relationships to Disclose
 
Lisa McShane
No Relationships to Disclose
 
Robert James Gray
Research Funding - Abbott Molecular; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; Janssen-Ortho; Millennium; Novartis; Onyx; Pfizer; Sanofi; Sequenta; Syndax
 
Shuli Li
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
Sherry Singer Ansher
No Relationships to Disclose
 
Stanley R. Hamilton
Consulting or Advisory Role - Bristol-Myers Squibb; HalioDx; Loxo; Merck; Philips Electronics; Thermo Fisher Scientific
 
Paul M. Williams
Patents, Royalties, Other Intellectual Property - I was a co-inventor of the DLBCL cell of origin patent recently filed by the NIH
 
James V. Tricoli
No Relationships to Disclose
 
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; KIYATEC; Lilly; Monogram Biosciences; Novartis; Roche; Seragon; Susan G. Komen for the Cure
Research Funding - AstraZeneca; Novartis; Puma Biotechnology; U3Pharma
 
Barbara A. Conley
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Bristol-Myers Squibb; Five Prime Therapeutics; Forty Seven; Genentech
Research Funding - Amgen; Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics
 
Alice P. Chen
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi